Inflammatory Bowel Disease (IBD) and Crohns disease: BPC-157 has been found to reduce inflammation, restore gut mucosa, and prevent damage in experimental colitis models, making it a potential therapeutic agent for Crohns disease and ulcerative colitis (Seiwerth et al., 2014)
However, no significant benefits were observed in nonglycemic laboratory outcomes and blood pressure, which could be attributed to the lack of abnormalities in participants at baseline
This, along with eating less overall, can sometimes lead to fewer bowel movements and constipation. Often, the constipation caused by semaglutide drugs like Ozempic is mild and temporary
Bench note: The easiest concentration to remember isnt always the best one
This guide breaks down the exact amount of bacteriostatic water to add for every common vial size